WallStreetZenWallStreetZen

NASDAQ: SRDX
Surmodics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SRDX past earnings growth

How has SRDX's earnings growth performed historically?
Company
N/A
Industry
88.02%
Market
107.96%
SRDX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SRDX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SRDX past revenue growth

How has SRDX's revenue growth performed historically?
Company
35.65%
Industry
9.4%
Market
17.57%
SRDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SRDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SRDX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SRDX earnings and revenue history

Current Revenue
$138.2M
Current Earnings
$5.5M
Current Profit Margin
4%
SRDX's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SRDX Return on Equity

Current Company
4.8%
Current Industry
10.5%
Current Market
188%
SRDX's Return on Equity (4.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SRDX announces earnings.

SRDX Return on Assets

Current Company
3.1%
Current Industry
5.3%
SRDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SRDX Return on Capital Employed

Current Company
8.14%
Current Industry
8.3%
SRDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SRDX vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SRDX$138.20M$22.74M$5.52M+9.81%-5.06%
PACB$200.52M-$277.28M-$306.74M+20.59%N/A
ANIK$166.66M-$71.19M-$82.67M+9.56%N/A
BVS$512.35M-$58.10M-$156.23M+9.93%N/A
NPCE$65.42M-$22.83M-$32.96M+15.33%N/A
View Top Medical Device Stocks

SRDX earnings dates

Next earnings date
Apr 24, 2024

Surmodics Earnings & Revenue FAQ

What were SRDX's earnings last quarter?

On Invalid Date, Surmodics (NASDAQ: SRDX) reported Q4 2023 earnings per share (EPS) of -$0.06, up 89.29% year over year. Total Surmodics earnings for the quarter were -$786.00 thousand. In the same quarter last year, Surmodics's earnings per share (EPS) was -$0.56.

If you're new to stock investing, here's how to buy Surmodics stock.

What was SRDX's earnings growth in the past year?

As of Q2 2024, Surmodics's earnings has grown year over year. Surmodics's earnings in the past year totalled $5.52 million.

What is SRDX's earnings date?

Surmodics's earnings date is Invalid Date. Add SRDX to your watchlist to be reminded of SRDX's next earnings announcement.

What was SRDX's revenue last quarter?

On Invalid Date, Surmodics (NASDAQ: SRDX) reported Q4 2023 revenue of $30.55 million up 22.54% year over year. In the same quarter last year, Surmodics's revenue was $24.93 million.

What was SRDX's revenue growth in the past year?

As of Q2 2024, Surmodics's revenue has grown 35.65% year over year. This is 26.25 percentage points higher than the US Medical Devices industry revenue growth rate of 9.4%. Surmodics's revenue in the past year totalled $138.20 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.